Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone. Another day is on the way, and this will be a busy one. We know you can relate. After all, this is the middle of the week and there is much to do. So please join us as we peruse the news of the world and celebrate the passing of another year with a much-needed cup of stimulation. Hope your day goes well and stay in touch...

Pfizer And deCode Genetics Ink Deal For Lupus Drug Targets (Xconomy)

Onyx Settles Claims With Bayer Over Cancer Drug (Reuters)

Pfizer Files Suit To Block Merck's Lipitor-Zetia Combo (Wall Street Journal)

Bayer Signs Deal For Manufacturing In Russia (InPharm)

FDA Adds Hypertension Warning To Bristol's Sprycel (Associated Press)

Lilly Names New Manufacturing And Biomedicines Execs (Reuters)

Pfizer Strikes $340M Deal For Sickle Cell Treatments (Pharma Times)

API Supplier Violated Hazardous Waste Laws (InPharma Technologist)

EDITOR'S NOTE: Please check this post for updates throughout the morning

cake pic thx to rejon on flickr